| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NRX | Common Stock | Exercise of in-the-money or at-the-money derivative security | $200 | +40,000 | +8.1% | $0.005000* | 532,977 | 28 Dec 2023 | Direct | |
| transaction | NRX | Common Stock | Sale | $198 | -76 | -0.01% | $2.61 | 532,901 | 28 Dec 2023 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NRX | Warrant (right to purchase) | Exercise of in-the-money or at-the-money derivative security | $0 | -40,000 | -100% | $0.000000* | 0 | 28 Dec 2023 | Common Stock | 40,000 | $0.005000 | Direct |
| Id | Content |
|---|---|
| F1 | On December 28, 2023, the reporting person exercised a warrant to purchase 40,000 shares of Neuraxis, Inc. (the "Company") common stock for $0.005 a share. The reporting person paid the exercise price on a cashless basis, resulting in the Company withholding 76 of the warrant shares to pay the exercise price and issuing the reporting person the remaining 39,924 shares. |